LI Kang Biomedical vs PEC: monthly revenue

Monthly revenue and year-on-year change for LI Kang Biomedical (6242) and PEC (6446) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ LI Kang Biomedical ━ PEC

0%+108%-45%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLI Kang BiomedicalYoYPECYoY
Oct 2026NT$53 million-8.1%NT$2.84 billion+102.0%
Sep 2026NT$41.9 million+7.6%NT$2.64 billion+100.0%
Aug 2026NT$37 million-0.5%NT$2.62 billion+105.4%
Jul 2026NT$42.1 million-0.1%NT$2.51 billion+92.6%
Jun 2026NT$49.9 million-8.3%NT$2.33 billion+94.9%
May 2026NT$58 million+7.9%NT$2.46 billion+108.5%
Apr 2026NT$54.1 million-4.2%NT$2.06 billion+68.3%
Mar 2026NT$53.5 million-7.9%NT$1.94 billion+64.4%
Feb 2026NT$24.4 million-44.6%NT$1.6 billion+56.7%
Jan 2026NT$43.7 million+33.6%NT$1.58 billion+49.8%
Dec 2025NT$54.8 million+3.3%NT$1.92 billion+69.9%
Nov 2025NT$59.2 million+10.2%NT$1.55 billion+53.0%
Oct 2025NT$57.6 million+0.8%NT$1.4 billion+53.6%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16